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Abstract
Advancements in neural machinery have led to a wide range of algorithmic so-
lutions for molecular property prediction. Two classes of models in particular have
yielded promising results: neural networks applied to computed molecular fingerprints
or expert-crafted descriptors, and graph convolutional neural networks that construct a
learned molecular representation by operating on the graph structure of the molecule.
However, recent literature has yet to clearly determine which of these two methods
is superior when generalizing to new chemical space. Furthermore, prior research has
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rarely examined these new models in industry research settings in comparison to ex-
isting employed models. In this paper, we benchmark models extensively on 19 public
and 16 proprietary industrial datasets spanning a wide variety of chemical endpoints.
In addition, we introduce a graph convolutional model that consistently matches or
outperforms models using fixed molecular descriptors as well as previous graph neural
architectures on both public and proprietary datasets. Our empirical findings indi-
cate that while approaches based on these representations have yet to reach the level
of experimental reproducibility, our proposed model nevertheless offers significant im-
provements over models currently used in industrial workflows.
Introduction
Molecular property prediction, one of the oldest cheminformatics tasks, has received new
attention in light of recent advancements in deep neural networks. These architectures either
operate over fixed molecular fingerprints common in traditional QSAR models, or they learn
their own task-specific representations using graph convolutions.1–11 Both approaches are
reported to yield substantial performance gains, raising state-of-the-art accuracy in property
prediction.
Despite these successes, many questions remain unanswered. The first question concerns
the comparison between learned molecular representations and fingerprints or descriptors.
Unfortunately, current published results on this topic do not provide a clear answer. Wu
et al. 2 demonstrate that convolution-based models typically outperform fingerprint-based
models, while experiments reported in Mayr et al. 12 report the opposite. Part of these
discrepancies can be attributed to differences in evaluation setup, including the way datasets
are constructed. This leads us to a broader question concerning current evaluation protocols
and their capacity to measure the generalization power of a method when applied to a new
chemical space, as is common in drug discovery. Unless special care is taken to replicate this
distributional shift in evaluation, neural models may overfit the training data but still score
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highly on the test data. This is particularly true for convolutional models that can learn
a poor molecular representation by memorizing the molecular scaffolds in the training data
and thereby fail to generalize to new ones. Therefore, a meaningful evaluation of property
prediction models needs to account explicitly for scaffold overlap between train and test data
in light of generalization requirements.
In this paper, we aim to answer both of these questions by designing a comprehensive
evaluation setup for assessing neural architectures. We also introduce an algorithm for
property prediction that outperforms existing strong baselines across a range of datasets.
The model has two distinctive features: (1) It operates over a hybrid representation that
combines convolutions and descriptors. This design gives it flexibility in learning a task
specific encoding, while providing a strong prior with fixed descriptors. (2) It learns to
construct molecular encodings by using convolutions centered on bonds instead of atoms,
thereby avoiding unnecessary loops during the message passing phase of the algorithm.
We extensively evaluate our model and other recently published neural architectures with
over 850 experiments on 19 publicly available benchmarks from Wu et al. 2 and Mayr et al. 12
and on 16 proprietary datasets from Amgen, Novartis, and BASF (Badische Anilin und Soda
Fabrik). Our goal is to assess whether the models’ performance on the public datasets and
their relative ranking are representative of their ranking on the proprietary datasets. We
demonstrate that under a scaffold split of training and testing data, the relative ranking of
the models is consistent across the two classes of datasets. We also show that a scaffold-
based split of the training and testing data is a good approximation of the temporal split
commonly used in industry in terms of the relevant metrics. By contrast, a purely random
split is a poor approximation to a temporal split, confirming the findings of Sheridan.13 To
put the performance of current models in perspective, we report bounds on experimental
error and show that there is still room for improving deep learning models to match the
accuracy and reproducibility of screening results.
Building on the diversity of our benchmark datasets, we explore the impact of molecular
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representation with respect to the dataset characteristics. We find that a hybrid repre-
sentation yields higher performance and generalizes better than either convolution-based or
fingerprint-based models. We also note that on small datasets (up to 1000 training molecules)
fingerprint models can outperform learned representations, which are negatively impacted
by data sparsity. Beyond molecular representation issues, we observe that hyperparameter
selection plays a crucial role in model performance, consistent with prior work.14 We show
that Bayesian optimization yields a robust, automatic solution to this issue. The addition
of ensembling further improves accuracy, again consistent with the literature.15
Our experiments show that our model achieves consistently strong out-of-the-box perfor-
mance and even stronger optimized performance across a wide variety of public and propri-
etary datasets. Our model achieves comparable or better performance on 11 out of 19 public
datasets and on 15 out of 16 proprietary datasets compared to all baseline models. Further-
more, no single baseline model is clearly superior across the remaining 8 public datasets, and
the relative performance of the baseline models often varies from dataset to dataset, whereas
our model is consistently strong across datasets. These results indicate that our model, and
learned molecular fingerprints in general, are applicable and ready to be used as a powerful
tool for chemists actively working on drug discovery.
Background
Since the core element of our model is a graph encoder architecture, our work is closely
related to previous work on graph encoders, such as those for social networks6,16 or for
chemistry applications.1,7–9,17–24
Common approaches to molecular property prediction today involve the application of
well-known models like support vector machines25 or random forests26 to expert-engineered
descriptors or molecular fingerprints, such as the Dragon descriptors27 or Morgan (ECFP)
fingerprints.28 One direction of advancement is the use of domain expertise to improve the
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base feature representation of molecular descriptors27,29–32 to drive better performance.12
Additionally, many studies have leveraged explicit 3D atomic coordinates to improve perfor-
mance further.2,33–36
The other main line of research is the optimization of the model architecture, whether
the model is applied to descriptors or fingerprints12,37 or is directly applied to SMILES38
strings12 or the underlying graph of the molecule.1–11 Our model belongs to the last category
of models, known as graph convolutional neural networks. In essence, such models learn their
own expert feature representations directly from the data, and they have been shown to be
very flexible and capable of capturing complex relationships given sufficient data.2,4
In a direction orthogonal to our own improvements, Ishiguro et al. 39 also make a strong
improvement to graph neural networks. Liu et al. 40 also evaluate their model against private
industry datasets, but we cannot compare against their method directly owing to dataset
differences.40
The property prediction models most similar to our own are encapsulated in the Message
Passing Neural Network (MPNN) framework presented in Gilmer et al..4 We build upon
this basic framework by adopting a message-passing paradigm based on updating represen-
tations of directed bonds rather than atoms. Additionally, we further improve the model by
combining computed molecule-level features with the molecular representation learned by
the MPNN.
Methods
We first summarize MPNNs in general using the terminology of Gilmer et al.,4 and then
we expand on the characteristics of Directed MPNN (D-MPNN)19 used in this paper. (D-
MPNN is originally called structure2vec in Dai et al..19 In this paper, we refer to it as
Directed MPNN to show it is a variant of the generic MPNN architecture.)
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Message Passing Neural Networks
An MPNN is a model which operates on an undirected graph G with node (atom) features
xv and edge (bond) features evw. MPNNs operate in two phases: a message passing phase,
which transmits information across the molecule to build a neural representation of the
molecule, and a readout phase, which uses the final representation of the molecule to make
predictions about the properties of interest.
More specifically, the message passing phase consists of T steps. On each step t, hidden
states htv and messages m
t
v associated with each vertex v are updated using message function
Mt and vertex update function Ut according to:
mt+1v =
∑
w∈N(v)
Mt(h
t
v, h
t
w, evw)
ht+1v = Ut(h
t
v,m
t+1
v )
where N(v) is the set of neighbors of v in graph G, and h0v is some function of the initial
atom features xv. The readout phase then uses a readout function R to make a property
prediction based on the final hidden states according to
yˆ = R({hTv |v ∈ G}).
The output yˆ may be either a scalar or a vector, depending on whether the MPNN is designed
to predict a single property or multiple properties (in a multitask setting).
During training, the network takes molecular graphs as input and makes an output
prediction for each molecule. A loss function is computed based on the predicted outputs
and the ground truth values, and the gradient of the loss is backpropagated through the
readout phase and the message passing phase. The entire model is trained end-to-end.
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Directed MPNN
The main difference between the Directed MPNN (D-MPNN)19 and the generic MPNN
described above is the nature of the messages sent during the message passing phase. Rather
than using messages associated with vertices (atoms), D-MPNN uses messages associated
with directed edges (bonds). The motivation of this design is to prevent totters41, that is,
to avoid messages being passed along any path of the form v1v2 · · · vn where vi = vi+2 for
some i. Such excursions are likely to introduce noise into the graph representation. Using
Figure 1 as an illustration, in D-MPNN, the message 1→ 2 will only be propagated to nodes
3 and 4 in the next iteration, whereas in the original MPNN it will be sent to node 1 as
well, creating an unnecessary loop in the message passing trajectory. Compared to the atom
based message passing approach, this message passing procedure is more similar to belief
propagation in probabilistic graphical models.42 We refer to Dai et al. 19 for futher discussion
about the connection between D-MPNN and belief propagation.
The D-MPNN works as follows. The D-MPNN operates on hidden states htvw and mes-
sages mtvw instead of on node based hidden states h
t
v and messages m
t
v. Note that the
direction of messages matters (i.e., htvw and m
t
vw are distinct from h
t
wv and m
t
wv). The
corresponding message passing update equations are thus
mt+1vw =
∑
k∈{N(v)\w}
Mt(xv, xk, h
t
kv)
ht+1vw = Ut(h
t
vw,m
t+1
vw ).
Observe that message mt+1vw does not depend on its reverse message m
t
wv from the previous
iteration. Prior to the first step of message passing, we initialize edge hidden states with
h0vw = τ(Wi cat(xv, evw))
where Wi ∈ Rh×hi is a learned matrix, cat(xv, evw) ∈ Rhi is the concatenation of the atom
7
(a)
(b)
(c)
Figure 1: Illustration of bond-level message passing in our proposed D-MPNN. (a): Messages
from the orange directed bonds are used to inform the update to the hidden state of the
red directed bond. By contrast, in a traditional MPNN, messages are passed from atoms
to atoms (for example atoms 1, 3, and 4 to atom 2) rather than from bonds to bonds. (b):
Similarly, a message from the green bond informs the update to the hidden state of the
purple directed bond. (c): Illustration of the update function to the hidden representation
of the red directed bond from diagram (a).
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features xv for atom v and the bond features evw for bond vw, and τ is the ReLU activation
function.43
We choose to use relatively simple message passing functions Mt and edge update func-
tions Ut. Specifically, we define Mt(xv, xw, h
t
vw) = h
t
vw and we implement Ut with the same
neural network on every step,
Ut(h
t
vw,m
t+1
vw ) = U(h
t
vw,m
t+1
vw ) = τ(h
0
vw +Wmm
t+1
vw )
where Wm ∈ Rh×h is a learned matrix with hidden size h. Note that the addition of h0vw on
every step provides a skip connection to the original feature vector for that edge.
Finally, we return to an atom representation of the molecule by summing the incoming
bond features according to
mv =
∑
k∈N(v)
hTkv
hv = τ(Wacat(xv,mv))
where Wa ∈ Rh×h is a learned matrix.
Altogether, the D-MPNN message passing phase operates according to
h0vw = τ(Wi cat(xv, evw))
followed by
mt+1vw =
∑
k∈{N(v)\w}
htkv
ht+1vw = τ(h
0
vw +Wmm
t+1
vw )
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for t ∈ {1, . . . , T}, followed by
mv =
∑
w∈N(v)
hTvw
hv = τ(Wacat(xv,mv)).
The readout phase of the D-MPNN is the same as the readout phase of a generic MPNN.
In our implementation of the readout function R, we first sum the atom hidden states to
obtain a feature vector for the molecule
h =
∑
v∈G
hv.
Finally, we generate property predictions yˆ = f(h) where f(·) is a feed-forward neural
network.
Initial Featurization
Our model’s initial atom and bond features are listed in Tables 1 and 2, respectively. The
D-MPNN’s initial node features xv are simply the atom features for that node, while the
D-MPNN’s initial edge features evw are the bond features for bond vw. All features are
computed using the open-source package RDKit.44
Table 1: Atom Features. All features are one-hot encodings except for atomic mass, which
is a real number scaled to be on the same order of magnitude.
Feature Description Size
Atom type Type of atom (ex. C, N, O), by atomic number. 100
# Bonds Number of bonds the atom is involved in. 6
Formal charge Integer electronic charge assigned to atom. 5
Chirality Unspecified, tetrahedral CW/CCW, or other. 4
# Hs Number of bonded Hydrogen atom. 5
Hybridization sp, sp2, sp3, sp3d, or sp3d2. 5
Aromaticity Whether this atom is part of an aromatic system. 1
Atomic mass Mass of the atom, divided by 100. 1
10
Table 2: Bond Features. All features are one-hot encodings.
Feature Description Size
Bond type Single, double, triple, or aromatic. 4
Conjugated Whether the bond is conjugated. 1
In ring Whether the bond is part of a ring. 1
Stereo None, any, E/Z or cis/trans. 6
D-MPNN with Features
Next, we discuss further extensions and optimizations to improve performance. Although
an MPNN should ideally be able to extract any information about a molecule that might be
relevant to predicting a given property, two limitations may prevent this in practice. First,
many property prediction datasets are very small, i.e., on the order of only hundreds or
thousands of molecules. With so little data, MPNNs are unable to learn to identify and
extract all features of a molecule that might be relevant to property prediction, and they are
susceptible to overfitting to artifacts in the data. Second, most MPNNs use fewer message
passing steps than the diameter of the molecular graph, i.e. T < diam(G), meaning atoms
that are a distance of greater than T bonds apart will never receive messages about each
other. This results in a molecular representation that is fundamentally local rather than
global in nature, meaning the MPNN may struggle to predict properties that depend heavily
on global features.
In order to counter these limitations, we introduce a variant of the D-MPNN that incor-
porates 200 global molecular features that can be computed rapidly in silico using RDKit.
The neural network architecture requires that the features are appropriately scaled to pre-
vent features with large ranges dominating smaller ranged features, as well as preventing
issues where features in the training set are not drawn from the same sample distribution
as features in the testing set. To prevent these issues, a large sample of molecules was used
to fit cumulative density functions (CDFs) to all features. CDFs were used as opposed to
simpler scaling algorithms mainly because CDFs have the useful property that each value
has the same meaning: the percentage of the population observed below the raw feature
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value. Min-max scaling can be easily biased with outliers and Z-score scaling assumes a
normal distribution which is most often not the case for chemical features, especially if they
are based on counts.
The CDFs were fit to a sample of 100k compounds from the Novartis internal catalog
using the distributions available in the scikit-learn package,45 a sample of which can be seen
in Figure 2. One could do a similar normalization using publicly available databases such as
ZINC46 and PubChem.47 scikit-learn was used primarily due to the simplicity of fitting and
the final application. However, more complicated techniques could be used in the future to
fit to empirical CDFs, such as finding the best fit general logistic function, which has been
shown to be successful for other biological datasets.48 No review was taken to remove odd
distributions. For example, azides are hazardous and rarely used outside of a few specific
reactions, as reflected in the fr azide distribution in Figure 2. As such, since the sample data
was primarily used for chemical screening against biological targets, the distribution used
here may not accurately reflect the distribution of reagents used for chemical synthesis. For
the full list of calculated features, please refer to the Supporting Information.
To incorporate these features, we modify the readout phase of the D-MPNN to apply the
feed-forward neural network f to the concatenation of the learned molecule feature vector h
and the computed global features hf ,
yˆ = f(cat(h, hf )).
This is a very general method of incorporating external information and can be used with
any MPNN and any computed features or descriptors.
Hyperparameter Optimization
The performance of MPNNs, like most neural networks, can depend greatly on the settings
of the various model hyperparameters, such as the hidden size of the neural network lay-
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(a) fr azide (b) Kappa2
(c) fr pyridine (d) BalabanJ
Figure 2: Four example distributions fit to a random sample of 100,000 compounds used for
biological screening in Novartis. Note that some distributions for discrete calculations, such
as fr pyridine, are not fit especially well. This is an active area for improvement.
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ers. Thus to maximize performance, we perform hyperparameter optimization via Bayesian
Optimization14 using the Hyperopt49 Python package. We specifically optimize our model’s
depth (number of message-passing steps), hidden size (size of bond message vectors), number
of feed-forward network layers, and dropout probability.
Ensembling
A common technique in machine learning for improving model performance is ensembling,
where the predictions of multiple independently trained models are combined to produce a
more accurate prediction.15 We apply this technique by training several copies of our model,
each initialized with different random weights, and then averaging the predictions of these
models (each with equal weight) to generate an ensemble prediction.
Since prior work did not report performance using ensembling, all direct comparisons
we make to prior work use a single D-MPNN model for a fair comparison. However, we
also report results using an ensemble to illustrate the maximum possible performance of our
model architecture.
Implementation
We implement our model using the PyTorch50 deep learning framework. All code for the
D-MPNN and its variants is available in our GitHub repository.51 Code for computing and
using the RDKit feature CDFs is available in the Descriptastorus package.52 Additionally,
a web demonstration of our model’s predictive capability on public datasets is available
online.53
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Experiments
Data
We test our model on 19 publicly available datasets from Wu et al. 2 and Mayr et al..12 These
datasets range in size from less than 200 molecules to over 450,000 molecules. They include
a wide range of regression and classification targets spanning quantum mechanics, physical
chemistry, biophysics, and physiology. Detailed descriptions are provided in Table 3.
Table 3: Descriptions of the public datasets used in this paper.
Dataset Category Description
QM7, QM8, QM9 Quantum Mechanics Computer-generated quantum mechanical properties
ESOL Physical Chemistry Water solubility
FreeSolv Physical Chemistry Hydration free energy in water
Lipophilicity Physical Chemistry Octanol/water distribution coefficients
PDBbind Biophysics Protein binding affinity
PCBA Biophysics Assorted biological assays
MUV Biophysics Assorted biological assays
HIV Biophysics Inhibition of HIV replication
BACE Biophysics Inhibition of human β-secretase 1
BBBP Physiology Ability to penetrate the blood-brain-barrier
Tox21 Physiology Toxicity
ToxCast Physiology Toxicity
SIDER Physiology Side effects of drugs
ClinTox Physiology Toxicity
ChEMBL Physiology Biological assays
Summary statistics for all the datasets are provided in Table 4, and further details on
the datasets are available in Wu et al.,2 with the exception of the ChEMBL dataset which is
described in Mayr et al..12 Additional information on the class balance of the classification
datasets is provided in the Supporting Information. Although most classification datasets
are reasonably balanced, the MUV dataset is particularly unbalanced, with only 0.2% of
molecules classified as positive. This makes our model unstable, leading to the wide variation
in performance on this dataset in the subsequent sections.
It is worth noting that for some datasets, the number of compounds in Table 4 does not
precisely match the numbers from Wu et al..2 This is because Wu et al. 2 included duplicate
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molecules in that count while we count the unique number of molecules. Additionally, we left
out one or two molecules which could not be processed by RDKit.44 However, the impact of
removing these molecules is negligible on overall model performance. Furthermore, we have
fewer molecules in QM7 because we used SMILES strings generated by Wu et al. 2 from the
original 3D coordinates in the dataset, but the SMILES conversion process failed for ∼ 300
molecules. For this reason, we do not directly compare our model’s performance on QM7 to
the QM7 performance numbers reported by Wu et al..2
Table 4: Summary statistics of the public datasets used in this paper. Note: PDBbind-F,
PDBbind-C, and PDBbind-R refer to the full, core, and refined PDBbind datasets from Wu
et al..2
Dataset # Tasks Task Type # Compounds Metric
QM7 1 Regression 6,830 MAE
QM8 12 Regression 21,786 MAE
QM9 12 Regression 133,885 MAE
ESOL 1 Regression 1,128 RMSE
FreeSolv 1 Regression 642 RMSE
Lipophilicity 1 Regression 4,200 RMSE
PDBbind-F 1 Regression 9,880 RMSE
PDBbind-C 1 Regression 168 RMSE
PDBbind-R 1 Regression 3,040 RMSE
PCBA 128 Classification 437,929 PRC-AUC
MUV 17 Classification 93,087 PRC-AUC
HIV 1 Classification 41,127 ROC-AUC
BACE 1 Classification 1,513 ROC-AUC
BBBP 1 Classification 2,039 ROC-AUC
Tox21 12 Classification 7,831 ROC-AUC
ToxCast 617 Classification 8,576 ROC-AUC
SIDER 27 Classification 1,427 ROC-AUC
ClinTox 2 Classification 1,478 ROC-AUC
ChEMBL 1,310 Classification 456,331 ROC-AUC
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Experimental Procedure
Cross-Validation and Hyperparameter Optimization. Since many of the datasets
are very small (two thousand molecules or fewer), we use a cross-validation approach to de-
crease noise in the results both while optimizing the hyperparameters and while determining
final performance numbers. For consistency, we maintain the same approach for all of our
datasets. Specifically, for each dataset, we use 20 iterations of Bayesian optimization on
10 randomly-seeded 80:10:10 data splits to determine the best hyperparameters, selecting
hyperparameters based on validation set performance. We then evaluate the model by re-
training using the optimal hyperparameters and checking performance on the test set. Due
to computational cost, we only use 3 splits for HIV, QM9, MUV, PCBA, and ChEMBL.
When we run the best model from Mayr et al. 12 for comparative purposes, we optimize
their model’s hyperparameters with the same splits, using their original hyperparameter
optimization script.
Split Type. We evaluate all models on random and scaffold-based splits as well as on the
original splits from Wu et al. 2 and Mayr et al..12 The one exception is the model of Mayr
et al.,12 which we only ran on scaffold-based splits, due to the large computational cost of
optimizing their model. Results on scaffold-based splits are reported below while results on
random splits are presented in the Supporting Information.
Our scaffold split is similar to that of Wu et al..2 Molecules are partitioned into bins based
on their Murcko scaffold calculated by RDKit.44 Any bins larger than half of the desired
test set size are placed into the training set, in order to guarantee the scaffold diversity
of the validation and test sets. All remaining bins are placed randomly into the training,
validation, and test sets until each set has reached its desired size. As this latter process
involves randomly placing scaffolds into bins, we are able to generate several different scaffold
splits for evaluation.
None of our splits on classification datasets are stratified; we do not enforce class balance.
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Compared to random splits, the scaffold splits have more class imbalance on average, but are
not excessively imbalanced; we analyze this class balance quantitatively in the Additional
Dataset Statistics section of the Supporting Information.
Compared to a random split, a scaffold split is a more challenging and realistic evaluation
setting as shown in Figures 11 and 13. This allows us to use a scaffold split as a proxy for
the chronological split present in real-world property prediction data, where one trains a
model on past data to make predictions on future data, although chronological splits are
still preferred when available. However, as chronological information is not available for
most public datasets, we use a scaffold-based split for all evaluations except for our direct
comparison with the MoleculeNet models from Wu et al.,2 for which we use their original
data splits.
Baselines. We compare our model to the following baselines:
• The best model for each dataset from MoleculeNet by Wu et al. 2
• The best model from Mayr et al.,12 a feed-forward neural network on a concatenation
of assorted expert-designed molecular fingerprints.
• Random forest on binary Morgan fingerprints.
• Feed-forward network (FFN) on binary Morgan fingerprints using the same FFN ar-
chitecture that our D-MPNN uses during its readout phase.
• FFN on count-based Morgan fingerprints.
• FFN on RDKit-calculated descriptors.
The models in MoleculeNet by Wu et al. 2 include MPNN,4 Weave,3 GraphConv, kernel
ridge regression, gradient boosting,54 random forest,26 logistic regression,55 directed acyclic
graph models,56 support vector machines,57 Deep Tensor Neural Networks,10 multitask net-
works,58 bypass networks,59 influence relevance voting,60 and/or ANI-1,61 depending on the
18
dataset. Full details can be found in Wu et al..2 For the feed-forward network model from
Mayr et al.,12 we modified the authors’ original code with their guidance in order to run
their code on all of the datasets, not just on the ChEMBL dataset they experimented with.
We tuned learning rates and hidden dimensions in addition to the extensive hyperparameter
search already present in their code.
Results and Discussion
In the following sections, we analyze the performance of our model on both public and
proprietary datasets. Specifically, we aim to answer the following questions:
1. How does our model perform on both public and proprietary datasets compared to pub-
lic benchmarks, and how close are we to the upper bound on performance represented
by experimental reproducibility?
2. How should we be splitting our data, and how does the method of splitting affect our
evaluation of the model’s generalization performance?
3. What are the key elements of our model, and how can we maximize its performance?
In the following sections, all results using root-mean-square error (RMSE) or mean abso-
lute error (MAE) are displayed as plots showing change relative to a baseline model rather
than showing absolute performance numbers. This is because the scale of the errors can
differ drastically between datasets. All results using R2, area under the receiver operating
characteristic curve (ROC-AUC), or area under the precision recall curve (PRC-AUC) are
displayed as plots showing the actual values. For RMSE and MAE, lower is better, while for
R2, ROC-AUC, and PRC-AUC, higher is better. Table 4 indicates the metric used for each
dataset. Tables showing the exact performance numbers for all experiments can be found in
the Supporting Information. Note that the error bars on all plots show the standard error
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of the mean across multiple runs, where standard error is defined as the standard deviation
divided by the square root of the number of runs.
We evaluate statistical significance using two statistical tests: a one-sided Wilcoxon
signed-rank test and a one-sided Welch’s t-test. While the Wilcoxon test is stronger, as it is a
paired test comparing performance molecule-by-molecule, it requires knowing per-molecule
predictions, which we do not have easy access to for the models from MoleculeNet2 and
Mayr et al..12 Furthermore, comparisons between data split types inherently involves com-
paring performance on different test molecules, meaning a per-molecule test is not possible.
Therefore, for these comparison we use the weaker Welch’s t-test and for all other compar-
isons we use the Wilcoxon test. When using the Wilcoxon test for regression datasets, we
directly compare test errors molecule-by-molecule. For the classification datasets, we divide
all the test molecules into 30 equal parts, compute AUC on each part, and then use the
Wilcoxon test on these AUC values. This subdivision of the test molecules into 30 parts
gives the Wilcoxon test more strength than evaluating directly on the original 3 or 10 test
cross-validation folds while still keeping each part large enough to result in a meaningful
AUC computation. We define statistical significance as p-value less than 0.05.
Additionally, note that in all figures and tables, “D-MPNN” refers to the base D-MPNN
model, “D-MPNN Features” refers to the D-MPNN with RDKit features, “D-MPNN Op-
timized” refers to the D-MPNN with RDKit features and optimized hyperparameters, and
“D-MPNN Ensemble” refers to an ensemble of five D-MPNNs with RDKit features and
optimized hyperparameters.
Comparison to Baselines
After optimizing our model, we compare our best single (non-ensembled) model on each
dataset against models from prior work.
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Comparison to MoleculeNet
We first compare our D-MPNN to the best model from MoleculeNet2,62 on the same datasets
and splits on which Wu et al. 2 evaluate their models. We were unable to reproduce their
original data splits on BACE, Toxcast, and QM7, but we have evaluated our model against
their original splits on all of the other datasets. The splits are a mix of random, scaffold,
and time splits, as indicated in Figure 3.
Overall on the 10 datasets where the MoleculeNet models only use 2D information, i.e.
all datasets except the QM and PDBbind datasets, our D-MPNN is significantly better than
the best MoleculeNet models on 5 datasets, is not significantly different on 3 datasets, and
is significantly worse on 2 datasets. This indicates that D-MPNN tends to outperform even
the best MoleculeNet models, with the added benefit that the D-MPNN model architecture
is the same for every dataset while the best MoleculeNet model architecture differs between
datasets.
Furthermore, we note that there are two cases in which our D-MPNN may underperform.
The first is the MUV dataset, which is large but extremely imbalanced; only 0.2% of samples
are labeled as positives. Wu et al. 2 also encountered great difficulty with this extreme class
imbalance when experimenting with the MUV dataset; all other datasets we experiment on
contain at least 1% positives (see the Supporting Information for full class balance informa-
tion). The second exception is when there is auxiliary 3D information available, as in the
three variants of the PDBbind dataset and in QM9. The current iteration of our D-MPNN
does not use 3D coordinate information, and we leave this extension to future work. Thus it
is unsurprising that our D-MPNN model underperforms models using 3D information on a
protein binding affinity prediction task such as PDBbind, where 3D structure is key. Never-
theless, our D-MPNN model outperforms the best graph-based method in MoleculeNet on
PDBbind and QM9. Moreover, we note that on another dataset that provides 3D coordinate
information, QM8, our model outperforms the best model in MoleculeNet with or without
3D coordinates.
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(a) Regression Datasets (lower = better).
(b) Classification Datasets (higher = better).
Figure 3: Comparison of our D-MPNN with features to the best models from Wu et al..2
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Comparison to Mayr et al. 12
In addition, we compare D-MPNN to the baseline from Mayr et al. 12 in Figure 4. We
reproduced the features from their best model on each dataset using their scripts or equiv-
alent packages.63 We then ran their code and hyperparameter optimization directly on the
classification datasets, and we modified their code to run on regression datasets with the
authors’ guidance.63 On most classification datasets, we obtain similar performance to Mayr
et al..12 On regression datasets, the baseline from Mayr et al. 12 performs poorly in compar-
ison, despite extensive tuning. We hypothesize that this poor performance on regression in
comparison to classification is the result of a large number of binary input features to the
output feed-forward network; this hypothesis is supported by the similarly poor performance
of our Morgan fingerprint FFN baseline. In addition, their method does not employ early
stopping based on validation set performance and therefore may overfit to the training data
in some cases; this may be the source of some numerical instability.
Overall, our D-MPNN is significantly better than the Mayr et al. 12 model on 8 datasets,
is not significantly different on 10 datasets, and is significantly worse on 1 dataset. This indi-
cates that D-MPNN generally outperforms the Mayr et al. 12 model, especially on regression
datasets.
Out-of-the-Box Comparison of D-MPNN to Other Baselines
For our final baseline comparison, we evaluate our model’s performance “out-of-the-box,” i.e.
using all the default settings (hidden size = 300, depth = 3, number of feed-forward layers
= 2, dropout = 0) without any hyperparameter optimization and without any additional
features. For this comparison, we compare to a number of simple baseline models that use
computed fingerprints or descriptors:
1. Random forest (RF) with 500 trees run on Morgan (ECFP) fingerprints using radius
2 and hashing to a bit vector of size 2048.
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(a) Regression Datasets (lower = better).
(b) Classification Datasets (higher = better).
Figure 4: Comparison of our best single model (i.e. optimized hyperparameters and RDKit
features) to the model from Mayr et al..
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2. Feed-forward network (FFN) on Morgan fingerprints.
3. FFN on Morgan fingerprints which use substructure counts instead of bits.
4. FFN on RDKit descriptors.
The parameters of the simple baseline models are also out-of-the-box defaults. We make
this comparison in order to demonstrate the strong out-of-the-box performance of our model
across a wide variety of datasets. Finally, we include the performance of the automatically
optimized version of our model as a reference.
Figure 5 shows that even without optimization, our D-MPNN provides an excellent start-
ing point on a wide variety of datasets and targets, though it can be improved further with
proper optimization.
Proprietary Datasets
We also ran our model on several private industry datasets, verifying that our model’s strong
performance on public datasets translates to real-world industrial datasets.
Amgen
We ran our model along with Mayr et al.’s12 model and our simple baselines on four internal
Amgen regression datasets. The datasets are as follows.
1. Rat plasma protein binding free fraction (rPPB).
2. Solubility in 0.01 M hydrochloric acid solution, pH 7.4 phosphate buffer solution, and
simulated intestinal fluid (Sol HCL, Sol PBS, and Sol SIF respectively).
3. Rat liver microsomes intrinsic clearance (RLM).
4. Human pregnane X receptor % activation at 2uM and 10uM (hPXR).
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(a) Regression Datasets (lower = better).
(b) Classification Datasets (higher = better).
Figure 5: Comparison of our unoptimized D-MPNN against several baseline models. We
omitted the random forest baseline on PCBA, MUV, Toxcast, and ChEMBL due to large
computational cost. The D-MPNN matches or outperforms all baselines on 11 of the 19
datasets.
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In addition, we binarized the hPXR dataset according to Amgen’s recommendations in
order to evaluate on a classification dataset. Details of the datasets are shown in Table 5.
Throughout the following, note that rPPB is in logit while Sol and RLM are in log10.
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Table 5: Details on internal Amgen datasets. Note: ADME stands for absorption, distribu-
tion, metabolism, and excretion.
Category Dataset # Tasks Task Type # Compounds Metric
ADME rPPB 1 Regression 1,441 RMSE
Physical Chemistry Solubility 3 Regression 18,007 RMSE
ADME RLM 1 Regression 64,862 RMSE
ADME hPXR 2 Regression 22,188 RMSE
ADME hPXR (class) 2 Classification 22,188 ROC-AUC
For each dataset, we evaluate on a chronological split. Our model outperforms the
baselines on 4 out of the 5 datasets, as shown in Figure 6. Thus our D-MPNN’s strong
performance on scaffold splits of public datasets can translate well to chronological splits of
private industry datasets.
BASF
We ran our model on 10 highly related quantum mechanical datasets from BASF. Each
dataset contains 13 properties calculated on the same 30,733 molecules, varying the solvent
in each dataset. Dataset details are in Table 6.
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(a) Regression Datasets (lower = better).
(b) Classification Datasets (higher = better).
Figure 6: Comparison of our D-MPNN against baseline models on Amgen internal datasets
on a chronological data split. D-MPNN outperforms almost all of the baselines. Note that
the ensembles were ensembles of 3 models rather than 5 for the Amgen datasets only. Also
note that RF on Morgan and Mayr et al FFN were only run once on RLM.
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Table 6: Details on internal BASF datasets. Note: R2 is the square of Pearson’s correlation
coefficient.
Category Dataset Tasks Task Type # Compounds Metric
Quantum Mechanics Benzene 13 regression 30,733 R2
Quantum Mechanics Cyclohexane 13 regression 30,733 R2
Quantum Mechanics Dichloromethane 13 regression 30,733 R2
Quantum Mechanics DMSO 13 regression 30,733 R2
Quantum Mechanics Ethanol 13 regression 30,733 R2
Quantum Mechanics Ethyl acetate 13 regression 30,733 R2
Quantum Mechanics H2O 13 regression 30,733 R2
Quantum Mechanics Octanol 13 regression 30,733 R2
Quantum Mechanics Tetrahydrofuran 13 regression 30,733 R2
Quantum Mechanics Toluene 13 regression 30,733 R2
For these datasets, we used a scaffold-based split because a chronological split was un-
available. We found that the model of Mayr et al. 12 is numerically unstable on these datasets,
and we therefore omit it from the comparison below. Once again we find that our model,
originally designed to succeed on a wide range of public datasets, is robust enough to transfer
to proprietary datasets as shown in Figure 7.
Novartis
Finally, we ran our model on one proprietary dataset from Novartis as described in Table 7.
As with other proprietary datasets, our D-MPNN outperforms the other baselines as shown
in Figure 8.
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Figure 7: Comparison of our D-MPNN against baseline models on BASF internal regression
datasets on a scaffold data split (higher = better). Our D-MPNN outperforms all baselines.
Table 7: Details on the internal Novartis dataset.
Category Dataset Tasks Task Type # Compounds Metric
Physical Chemistry logP 1 regression 20,294 RMSE
Experimental Error
As a final “oracle” baseline, we compare our model’s performance with to an experimental
upper upper bound: the agreement between multiple runs of the same assay, which we refer
to as the experimental error. Figure 9 shows the R2 of our model on the private Amgen
regression datasets together with the experimental error; in addition, this graph shows the
performance of Amgen’s internal model using expert-crafted descriptors. Both models remain
far less accurate than the corresponding ground truth assays. Thus there remains significant
space for further performance improvement in the future.
31
Figure 8: Comparison of our D-MPNN against baseline models on the Novartis internal
regression dataset on a chronological data split (lower = better). Our D-MPNN outperforms
all baseline models.
Analysis of Split Type
We now justify our use of scaffold splits for performance evaluation. The ultimate goal of
building a property prediction model is to predict properties on new chemistry in order to
aid the search for drugs from new classes of molecules. On proprietary company datasets,
performance on new chemistry is evaluated using a chronological split of the data, i.e.,
everything before a certain date serves as the training set while everything after that date
serves as the test set. This approximates model performance on molecules that chemists are
likely to investigate in the future. Since chronological data is typically unavailable for public
datasets, we investigate whether we can use our scaffold split as a reasonable proxy for a
chronological split, following the work of Sheridan.13
Figure 10 provides motivation for a scaffold split approach. As illustrated in the figure,
train and test sets according to a chronological split share fewer molecular scaffolds than
train and test sets split randomly. Since our scaffold split enforces zero molecular scaffold
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Figure 9: Comparison of Amgen’s internal model and our D-MPNN (evaluated using a
single run on a chronological split) to experimental error (higher = better). Note that the
experimental error is not evaluated on the exact same time split as the two models since
it can only be measured on molecules which were tested more than once, but even so the
difference in performance is striking.
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overlap between the train and test set, it should ideally provide a split that is at least as
difficult as a chronological split.
As illustrated in Figures 11, 12, and 13, performance on our scaffold split is on average
closer to performance on a chronological split on proprietary datasets from Amgen and
Novartis and on the public PDBbind datasets. However, the results are noisy due to the
nature of chronological splitting, where we only have a single data split, as opposed to random
and scaffold splitting, which both have a random component and can generate different splits
depending on the random seed. We can alleviate the problem with noise in chronological
datasets by using a sliding time window to get different equally-sized splits, at the cost of
significantly decreasing the dataset size. We report results on such sliding window splits in
the Supporting Information, as the conclusions from these splits are qualitatively similar to
those in the main paper.
Figure 14 shows the difference between a random split and a scaffold split on the publicly
available datasets, further demonstrating that a scaffold split generally results in a more
difficult, and ideally more useful, measure of performance. Therefore, all of our results
are reported on a scaffold split rather than a random split in order to better reflect the
generalization ability of our model on new chemistry. Nevertheless, it should be emphasized
that the chronological split is still the ideal split on which to evaluate when it is available.
Thus we additionally report the results on chronological splits on all datasets where they are
available.
Overall, our results confirm the findings of Sheridan 13 that scaffold and chronological
splits are more difficult than random splits, and hence scaffold splits should be preferred
over random splits during evaluation. Our findings differ somewhat from those in Sheri-
dan 13 in that we find some evidence that chronological splits may actually be harder than
scaffold splits. However, owing to the small number of datasets where chronological splits
are available, further investigation is necessary on this point, ideally on a larger range of
datasets.
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Figure 10: Overlap of molecular scaffolds between the train and test sets for a random or
chronological split of four Amgen regression datasets. Overlap is defined as the percent of
molecules in the test set which share a scaffold with a molecule in the train set.
Ablations
Finally, we analyze and justify our modeling choices and optimizations.
Message Type
The most important distinction between our D-MPNN and related work is the nature of
the messages being passed across the molecule. Most prior work uses messages centered
on atoms whereas our D-MPNN uses messages centered on directed bonds. To isolate the
effect of the message passing paradigm on property prediction performance, we implemented
message passing on undirected bonds and on atoms as well, as detailed in the Supporting
Information and in our code. Figure 15 illustrates the differences in performance between
these three types of message passing. While on average the method using directed bonds
outperforms the alternatives, the results are largely not statistically significant, so more
investigation is warranted on this point.
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Figure 11: Performance of D-MPNN on four Amgen regression datasets according to three
methods of splitting the data (lower = better). The chronological split is significantly harder
than both random and scaffold on Sol and hPXR, while the scaffold split is significantly
harder than the random split on Sol only.
Figure 12: Performance of D-MPNN on the Novartis regression dataset according to three
methods of splitting the data (lower = better). The chronological split is significantly harder
than the random split while the scaffold split is not.
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Figure 13: Performance of D-MPNN on the full (F), core (C), and refined (R) subsets of the
PDBbind dataset according to three methods of splitting the data (lower = better). The
chronological and scaffold splits are significantly harder than the random split in all cases
except for the PDBbind-C scaffold split.
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(a) Regression Datasets (lower = better).
(b) Classification Datasets (higher = better).
Figure 14: Performance of D-MPNN on random and scaffold splits for several public datasets.
Only the results on PDBbind-C, HIV, ClinTox, and ChEMBL are not statistically significant.
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RDKit Features
Next, we examined the impact of adding additional molecule-level features from RDKit to our
model. Figure 16 shows the effect on model performance. The results appear to be highly
dataset-dependent. Some datasets, such as QM9 and ESOL, show marked improvement
with the addition of features, while other datasets, such as PCBA and HIV, actually show
worse performance with the features. We hypothesize that this is because the features are
particularly relevant to certain tasks while possibly confusing and distracting the model on
other tasks. This implies that our model’s performance on a given dataset may be further
optimized by selecting different features more relevant to the task of interest.
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(a) Regression Datasets (lower = better).
(b) Classification Datasets (higher = better).
Figure 15: Comparison of performance of different message passing paradigms.
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Another interesting trend is the effect of adding features to the three PDBbind datasets.
The features appear to help on all three datasets, but the benefit is much more pronounced on
the extremely small PDBbind-C (core) dataset than it is on the larger PDBbind-R (refined)
and PDBbind-F (full) datasets. This indicates that the features may help compensate for
the lack of training data and thus may be particularly relevant in low-data regimes. In
particular, we hypothesize that the features may help to regularize a representation derived
from a small dataset: because the features are derived from more general chemical knowledge,
they implicitly provide the model some understanding of a larger chemical domain. Thus, it
is worthwhile to consider the addition of features both when they are particularly relevant
to the task of interest and when the dataset is especially small.
Hyperparameter Optimization
To improve model performance, we performed Bayesian Optimization to select the best
model hyperparameters for each dataset. Figure 17 illustrates the benefit of performing
this optimization, as model performance improves on virtually every dataset. Interestingly,
some datasets are particularly sensitive to hyperparameters. While most datasets experience
a moderate 2-5% improvement in performance following hyperparameter optimization, the
quantum mechanics datasets (QM7, QM8, and QM9) and PCBA see dramatic improvements
in performance, with our D-MPNN model performing 37% better on QM9 after optimization.
Ensembling
To maximize performance, we trained an ensemble of models. For each dataset, we selected
the best single model—i.e. the best hyperparameters along with the RDKit features if the
features improved performance—and we trained five models instead of one. The results
appear in Figure 19. On most datasets, ensembling only provides a small 1-5% benefit, but
as with hyperparameter optimization, there are certain datasets, particularly the quantum
mechanics datasets, which especially benefit from the effect of ensembling.
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(a) Regression Datasets (lower = better).
(b) Classification Datasets (higher = better).
Figure 16: Effect of adding molecule-level features generated with RDKit to our model.
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(a) Regression Datasets (lower = better).
(b) Classification Datasets (higher = better).
Figure 17: Effect of performing Bayesian hyperparameter optimization on the depth, hidden
size, number of fully connected layers, and dropout of the D-MPNN.
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Figure 18: An illustration of ensembling models. On the left is a single model, which takes
input and makes a prediction. On the right is an ensemble of 3 models. Each model takes
the same input and makes a prediction independently, and then the predictions are averaged
to generate the ensemble’s prediction.
While each of the latter three optimizations (RDKit descriptors, hyperparameter op-
timization, and ensembling) on its own has limited benefits, altogether they significantly
improve the model’s performance on every dataset except MUV.
Effect of Data Size
Finally, we analyze the effect of data size on the performance of our model, using the
ChEMBL dataset. ChEMBL is a large dataset of 456,331 molecules on 1,310 targets, but is
extremely sparse: only half of the 1,310 targets have at least 300 labels. For this analysis, we
use the original scaffold-based split of Mayr et al.,12 containing 3 cross-validation folds. From
Figure 20, we hypothesize that our D-MPNN struggles on low-label targets in comparison
to this baseline. As our D-MPNN model does not use any human-engineered fingerprints or
descriptors and must therefore learn its features completely from scratch based on the input
data, it would be unsurprising if the average ROC-AUC score of D-MPNN is worse than
that of the feed-forward network running on human-engineered descriptors in Mayr et al..12
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(a) Regression Datasets (lower = better).
(b) Classification Datasets (higher = better).
Figure 19: Effect of using an ensemble of five models instead of a single model.
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When we filter the ChEMBL dataset by pruning low-data targets at different thresholds, we
find that our D-MPNN indeed may outperform the best model of Mayr et al. 12 at larger
data thresholds (Figure 20), though our results are not fully conclusive.
Figure 20: Effect of data size on the performance of the model from Mayr et al. 12 and of
our D-MPNN model (higher = better). All comparisons besides the first are statistically
significant.
Conclusion and Future Work
Table 8: Number of public datasets where D-MPNN is statistically significantly better than,
equivalent to, or worse than each baseline model.
Baseline D-MPNN is better D-MPNN is same D-MPNN is worse # datasets
MoleculeNet2 5 3 2 10
Mayr et al. 12 8 10 1 19
RF on Morgan 9 1 4 15
FFN on Morgan 14 5 0 19
FFN on Morgan Counts 15 4 0 19
FFN on RDKit 8 5 4 19
In this paper, we performed an extensive comparison of molecular property prediction
models based on either fixed descriptors or learned molecular representations by performing
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over 850 experiments on 19 public and 16 proprietary datasets. Table 8 shows a summary of
how our D-MPNN compares to each of the baseline models. Our model consistently matches
or outperforms each baseline individually, and across all baselines, our model achieves com-
parable or better performance on 11 of the 19 public datasets: QM7, QM8, QM9, ESOL,
FreeSolv, Lipophilicity, BBBP, PDBbind-F, PCBA, Tox21, and ClinTox. On the remain-
ing 8 datasets, no single baseline model is consistently superior. Furthermore, our model’s
strong results transfer to proprietary datasets, where our model outperforms the random
forest, feed-forward neural network, and Mayr et al. 12 models on 15 out of the 16 datasets.
The strong performance of our model over these baselines, many of which use computed
fingerprints or descriptors, demonstrate that learned molecular representations are indeed
ready for “prime time” use in industrial property prediction settings.
Nevertheless, several avenues for future research remain. When analyzing the perfor-
mance of our D-MPNN, we found that it typically underperforms when either 1) the other
models incorporate 3D information, as in MoleculeNet’s best QM and PDBbind models, 2)
the dataset is especially small, as in the PDBbind-C dataset, or 3) the classes are particu-
larly imbalanced, as in the MUV dataset. One avenue of improvement is the incorporation
of additional 3D information into our model, which currently includes only a very restricted
and naive representation of such features. Another potential improvement is a principled
pretraining approach, which some authors have already begun to explore.64,65 Such an ap-
proach could enable models to transfer learning from large chemical datasets to much smaller
datasets, thereby improving performance in limited data settings. Another direction for fu-
ture research is to determine how to adapt models and training algorithms to classification
datasets with extreme class imbalance. Finally, in addition to these potential improvements,
our analysis of how estimation of model generalizability is affected by split type opens the
door to future work in uncertainty quantification and domain of applicability assessment.
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